University Hospitals Seidman Cancer Center researchers have developed a tool that could identify metastatic prostate cancer ...

Three-year study will test biopsy analysis tool shown in trials to identify men likely to benefit from certain drugs A tool that uses artificial intelligence to help diagnose men with prostate cancer ...

California-based Artera, a company that develops multimodal AI-based prognostic and predictive cancer tests, has been granted de novo authorization by the FDA for its AI tool for prostate cancer ...

The UCLA trial is currently enrolling patients.